Re: Ultrasound Demonstration of Testicular Microlithiasis in Pediatric Patients: Is There an Association with Testicular Germ Cell Tumors?

2016 ◽  
Vol 196 (1) ◽  
pp. 226-226
Author(s):  
Douglas A. Canning
2004 ◽  
Vol 171 (1) ◽  
pp. 158-160 ◽  
Author(s):  
C. A. de GOUVEIA BRAZAO ◽  
F.H. PIERIK ◽  
J.W. OOSTERHUIS ◽  
G.R. DOHLE ◽  
L.H.J. LOOIJENGA ◽  
...  

Cancer ◽  
2010 ◽  
Vol 116 (19) ◽  
pp. 4520-4532 ◽  
Author(s):  
Iain B. Tan ◽  
Kai K. Ang ◽  
Boon C. Ching ◽  
Chandra Mohan ◽  
Chee K. Toh ◽  
...  

2018 ◽  
Vol 20 (6) ◽  
pp. 593 ◽  
Author(s):  
MarinaV Nemtsova ◽  
IlyaS Dantsev ◽  
EvgeniyV Ivkin ◽  
AlekseyA Tryakin ◽  
DmitriyN Godlevski ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1652
Author(s):  
Andreas Stang ◽  
Mary L. McMaster ◽  
Isabell A. Sesterhenn ◽  
Elizabeth Rapley ◽  
Robert Huddart ◽  
...  

This study aimed to compare histological features of familial and sporadic testicular germ cell tumors (TGCTs) and surrounding parenchyma, since discriminating features might be etiologically relevant and clinically useful. The study of parenchyma was prompted by reports claiming a higher prevalence of testicular microlithiasis in familial cases. Histological features of TGCTs and surrounding parenchyma of 296 sporadic and 305 familial cases were compared. For each case, one representative hematoxylin and eosin-stained slide was available. Slides were independently scored by two expert pathologists using a semi-quantitative data abstract. Discrepancies were resolved by consensus. A logistic regression model was used to assess the ability to discriminate between sporadic and familial GCT. The histological composition of a tumor, amount of lymphocytic infiltration, amount of germ cell neoplasia in situ (GCNIS), and presence of testicular microlithiasis (TM) did not discriminate between sporadic and familial GCT (area under the curve 0.56, 95%CI 0.51–0.61). Novel observations included increasing lymphocytic infiltration and decreasing GCNIS and TM with increasing age at diagnosis. The presence of tubules with infiltrating lymphocytes was mainly associated with pure seminomas and nonseminomas with a seminoma component. Among seminomas, tubules with infiltrating lymphocytes decreased with increasing age. No discernable differences between sporadic and familial TGCTs were found. The age-related changes in the tumors and surrounding parenchyma in these groups combined are consistent with a host response building up over time predominantly affecting seminomas, the seminoma-component of nonseminomas and GCNIS. TM may gradually dissolve with age. Our hypothesis that histological differences between sporadic and familial TGCT might identify genetically distinct disease subsets was not supported.


2001 ◽  
Vol 40 (4) ◽  
pp. 536-540 ◽  
Author(s):  
Finn Edler von Eyben ◽  
Ebbe Lindegaard Madsen ◽  
Ole Blaabjerg ◽  
Per Hyltoft Petersen ◽  
Hans von der Maase ◽  
...  

2018 ◽  
Vol 18 (10) ◽  
pp. 967-978 ◽  
Author(s):  
Katarina Kalavska ◽  
Vincenza Conteduca ◽  
Ugo De Giorgi ◽  
Michal Mego

Testicular germ cell tumors (TGCTs) represent the most common malignancy in men aged 15-35. Due to these tumors’ biological and clinical characteristics, they can serve as an appropriate system for studying molecular mechanisms associated with cisplatin-based treatment resistance. This review describes treatment resistance from clinical and molecular viewpoints. Cisplatin resistance is determined by various biological mechanisms, including the modulation of the DNA repair capacity of cancer cells, alterations to apoptotic cell death pathways, deregulation of gene expression pathways, epigenetic alterations and insufficient DNA binding. Moreover, this review describes TGCTs as a model system that enables the study of the cellular features of cancer stem cells in metastatic process and describes experimental models that can be used to study treatment resistance in TGCTs. All of the abovementioned aspects may help to elucidate the molecular mechanisms underlying cisplatin resistance and may help to identify promising new therapeutic targets.


Sign in / Sign up

Export Citation Format

Share Document